GlassScriptPhysician profile
Matthew C Axtman
NPI 1255478988
$483.58
in general payments reported to CMS, 2019-2025
7 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.74 · 2020: $75.33 · 2022: $32.87 · 2023: $98.83 · 2024: $91.83 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $194.10 | 2022-2025 | Euflexxa |
| Medwest Associates | $75.33 | 2020 | |
| Bioventus LLC | $72.23 | 2025 | Durolane, Exogen Ultrasound Bone Healing System |
| My01 INC. | $51.00 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Zimmer Biomet Holdings, INC. | $45.75 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Orthofix Medical, INC. | $28.78 | 2019-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $16.39 | 2024 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Axtman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.